Interventional Oncology Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type
By: HDIN Research
Published: 2025-05-04
Pages: 124
Market Research Report Price
- Single User License (1 Users) $ 4,000
- Team License (2~5 Users) $ 5,000
- Corporate License (>5 Users) $ 6,000
Interventional Oncology Market Summary
Introduction
Interventional Oncology involves minimally invasive procedures like embolization, ablation, and support devices to treat cancer, used in hospitals, ambulatory surgery centers, and research institutes. These techniques offer targeted therapy, reducing recovery times and improving outcomes. The market is characterized by its role in cancer care, driven by rising cancer incidence (2.04 million new U.S. cases projected in 2025 per American Cancer Society), technological advancements, and demand for minimally invasive treatments. Trends include image-guided ablation, drug-eluting embolization, and AI-enhanced procedures, with growing demand in emerging markets due to healthcare advancements.
Market Size and Growth Forecast
The global Interventional Oncology market was valued at USD 1.9–2.9 billion in 2024, with an estimated CAGR of 7.5%–9.5% from 2025 to 2030, propelled by cancer prevalence and minimally invasive trends.
Regional Analysis
North America grows at 7.0%–9.0%; the U.S. leads due to high cancer incidence, with trends focusing on image-guided ablation.
Europe achieves 6.8%–8.8% growth; Germany and the UK drive demand through advanced oncology, emphasizing drug-eluting embolization.
Asia Pacific records 8.0%–10.0% growth; China and Japan are key markets, with trends toward AI-enhanced procedures.
Rest of the World grows at 6.5%–8.5%; Brazil and India show potential, with trends centering on hospital applications.
Application Analysis
Hospitals expand at 7.8%–9.8%; they drive procedure volume, with trends favoring advanced ablation.
Ambulatory Surgery Centers grow at 7.3%–9.3%; they support outpatient care, emphasizing embolization.
Research & Academic Institutes rise at 6.8%–8.8%; they drive innovation, with trends focusing on AI integration.
Type Analysis
Embolization Devices expand at 7.5%–9.5%; they target tumor blood supply, with trends favoring drug-eluting beads.
Ablation Devices grow at 7.8%–9.8%; they destroy tumors, emphasizing image-guided systems.
Support Devices rise at 6.8%–8.8%; they aid procedures, with trends focusing on microcatheters.
Key Market Players
Medtronic, based in Dublin, Ireland, is a leader in oncology devices, offering ablation systems. Medtronic is developing AI-enhanced tools and targeting Asia.
Boston Scientific, headquartered in Marlborough, Massachusetts, USA, provides embolization devices, known for precision. Boston Scientific is targeting Europe.
BD, from Franklin Lakes, New Jersey, USA, supplies support devices, emphasizing reliability. BD is targeting Latin America.
Terumo, based in Tokyo, Japan, offers microcatheters, known for innovation. Terumo is targeting India.
Merit Medical, headquartered in South Jordan, Utah, USA, provides embolization devices, focusing on scalability. Merit is targeting Africa.
AngioDynamics, from Latham, New York, USA, supplies ablation systems, emphasizing efficiency. AngioDynamics is targeting China.
Johnson & Johnson, based in New Brunswick, New Jersey, USA, offers oncology devices, focusing on durability. J&J is targeting Southeast Asia.
Teleflex, headquartered in Wayne, Pennsylvania, USA, provides support devices, known for precision. Teleflex is targeting Brazil.
Cook Medical, from Bloomington, Indiana, USA, supplies embolization devices, emphasizing affordability. Cook is targeting the Middle East.
HealthTronics, based in Austin, Texas, USA, offers ablation services, focusing on outpatient care. HealthTronics is targeting North America.
Porter’s Five Forces Analysis
● The threat of new entrants is moderate; high R&D and regulatory barriers deter entry, but cancer demand attracts niche players.
● The threat of substitutes is moderate; surgical oncology competes, but minimally invasive procedures retain preference.
● Buyer power is moderate; hospitals demand efficacy, but large buyers negotiate pricing.
● Supplier power is low; device materials are widely available, reducing supplier leverage.
● Competitive rivalry is high; firms differentiate through image-guided systems, drug-eluting beads, and AI integration.
Market Opportunities and Challenges
Opportunities
● Rising cancer incidence (618,120 U.S. deaths projected in 2025 per American Cancer Society) drives demand.
● AI-enhanced and drug-eluting devices enhance market growth.
● Emerging markets offer expansion as oncology care grows in Asia and Africa.
Challenges
● High costs of advanced devices limit adoption in low-resource regions.
● Regulatory complexity for oncology devices increases compliance costs.
● Intense competition pressures pricing for branded devices.
Growth Trend Analysis
The Interventional Oncology market is growing robustly, driven by cancer prevalence and minimally invasive trends. Boston Scientific’s acquisition of Intera Oncology on November 27, 2024, expands its portfolio. Teleflex’s acquisition of Biotronik’s Vascular Intervention business on February 27, 2025, and Argon Medical’s acquisition of Accurate Medical Therapeutics on January 14, 2025, strengthen offerings. Merit Medical’s $210M device portfolio acquisition on September 18, 2024, Merck’s $1.3bn acquisition of Modifi Biosciences on October 29, 2024, AngioDynamics’ NanoKnife study on October 24, 2024, and CancerX’s 2025 Accelerator on February 17, 2025, align with a projected CAGR of 7.5%–9.5% through 2030.
Introduction
Interventional Oncology involves minimally invasive procedures like embolization, ablation, and support devices to treat cancer, used in hospitals, ambulatory surgery centers, and research institutes. These techniques offer targeted therapy, reducing recovery times and improving outcomes. The market is characterized by its role in cancer care, driven by rising cancer incidence (2.04 million new U.S. cases projected in 2025 per American Cancer Society), technological advancements, and demand for minimally invasive treatments. Trends include image-guided ablation, drug-eluting embolization, and AI-enhanced procedures, with growing demand in emerging markets due to healthcare advancements.
Market Size and Growth Forecast
The global Interventional Oncology market was valued at USD 1.9–2.9 billion in 2024, with an estimated CAGR of 7.5%–9.5% from 2025 to 2030, propelled by cancer prevalence and minimally invasive trends.
Regional Analysis
North America grows at 7.0%–9.0%; the U.S. leads due to high cancer incidence, with trends focusing on image-guided ablation.
Europe achieves 6.8%–8.8% growth; Germany and the UK drive demand through advanced oncology, emphasizing drug-eluting embolization.
Asia Pacific records 8.0%–10.0% growth; China and Japan are key markets, with trends toward AI-enhanced procedures.
Rest of the World grows at 6.5%–8.5%; Brazil and India show potential, with trends centering on hospital applications.
Application Analysis
Hospitals expand at 7.8%–9.8%; they drive procedure volume, with trends favoring advanced ablation.
Ambulatory Surgery Centers grow at 7.3%–9.3%; they support outpatient care, emphasizing embolization.
Research & Academic Institutes rise at 6.8%–8.8%; they drive innovation, with trends focusing on AI integration.
Type Analysis
Embolization Devices expand at 7.5%–9.5%; they target tumor blood supply, with trends favoring drug-eluting beads.
Ablation Devices grow at 7.8%–9.8%; they destroy tumors, emphasizing image-guided systems.
Support Devices rise at 6.8%–8.8%; they aid procedures, with trends focusing on microcatheters.
Key Market Players
Medtronic, based in Dublin, Ireland, is a leader in oncology devices, offering ablation systems. Medtronic is developing AI-enhanced tools and targeting Asia.
Boston Scientific, headquartered in Marlborough, Massachusetts, USA, provides embolization devices, known for precision. Boston Scientific is targeting Europe.
BD, from Franklin Lakes, New Jersey, USA, supplies support devices, emphasizing reliability. BD is targeting Latin America.
Terumo, based in Tokyo, Japan, offers microcatheters, known for innovation. Terumo is targeting India.
Merit Medical, headquartered in South Jordan, Utah, USA, provides embolization devices, focusing on scalability. Merit is targeting Africa.
AngioDynamics, from Latham, New York, USA, supplies ablation systems, emphasizing efficiency. AngioDynamics is targeting China.
Johnson & Johnson, based in New Brunswick, New Jersey, USA, offers oncology devices, focusing on durability. J&J is targeting Southeast Asia.
Teleflex, headquartered in Wayne, Pennsylvania, USA, provides support devices, known for precision. Teleflex is targeting Brazil.
Cook Medical, from Bloomington, Indiana, USA, supplies embolization devices, emphasizing affordability. Cook is targeting the Middle East.
HealthTronics, based in Austin, Texas, USA, offers ablation services, focusing on outpatient care. HealthTronics is targeting North America.
Porter’s Five Forces Analysis
● The threat of new entrants is moderate; high R&D and regulatory barriers deter entry, but cancer demand attracts niche players.
● The threat of substitutes is moderate; surgical oncology competes, but minimally invasive procedures retain preference.
● Buyer power is moderate; hospitals demand efficacy, but large buyers negotiate pricing.
● Supplier power is low; device materials are widely available, reducing supplier leverage.
● Competitive rivalry is high; firms differentiate through image-guided systems, drug-eluting beads, and AI integration.
Market Opportunities and Challenges
Opportunities
● Rising cancer incidence (618,120 U.S. deaths projected in 2025 per American Cancer Society) drives demand.
● AI-enhanced and drug-eluting devices enhance market growth.
● Emerging markets offer expansion as oncology care grows in Asia and Africa.
Challenges
● High costs of advanced devices limit adoption in low-resource regions.
● Regulatory complexity for oncology devices increases compliance costs.
● Intense competition pressures pricing for branded devices.
Growth Trend Analysis
The Interventional Oncology market is growing robustly, driven by cancer prevalence and minimally invasive trends. Boston Scientific’s acquisition of Intera Oncology on November 27, 2024, expands its portfolio. Teleflex’s acquisition of Biotronik’s Vascular Intervention business on February 27, 2025, and Argon Medical’s acquisition of Accurate Medical Therapeutics on January 14, 2025, strengthen offerings. Merit Medical’s $210M device portfolio acquisition on September 18, 2024, Merck’s $1.3bn acquisition of Modifi Biosciences on October 29, 2024, AngioDynamics’ NanoKnife study on October 24, 2024, and CancerX’s 2025 Accelerator on February 17, 2025, align with a projected CAGR of 7.5%–9.5% through 2030.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Interventional Oncology Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Interventional Oncology Market in North America (2020-2030)
8.1 Interventional Oncology Market Size
8.2 Interventional Oncology Market by End Use
8.3 Competition by Players/Suppliers
8.4 Interventional Oncology Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Interventional Oncology Market in South America (2020-2030)
9.1 Interventional Oncology Market Size
9.2 Interventional Oncology Market by End Use
9.3 Competition by Players/Suppliers
9.4 Interventional Oncology Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Interventional Oncology Market in Asia & Pacific (2020-2030)
10.1 Interventional Oncology Market Size
10.2 Interventional Oncology Market by End Use
10.3 Competition by Players/Suppliers
10.4 Interventional Oncology Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Interventional Oncology Market in Europe (2020-2030)
11.1 Interventional Oncology Market Size
11.2 Interventional Oncology Market by End Use
11.3 Competition by Players/Suppliers
11.4 Interventional Oncology Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Interventional Oncology Market in MEA (2020-2030)
12.1 Interventional Oncology Market Size
12.2 Interventional Oncology Market by End Use
12.3 Competition by Players/Suppliers
12.4 Interventional Oncology Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Interventional Oncology Market (2020-2025)
13.1 Interventional Oncology Market Size
13.2 Interventional Oncology Market by End Use
13.3 Competition by Players/Suppliers
13.4 Interventional Oncology Market Size by Type
Chapter 14 Global Interventional Oncology Market Forecast (2025-2030)
14.1 Interventional Oncology Market Size Forecast
14.2 Interventional Oncology Application Forecast
14.3 Competition by Players/Suppliers
14.4 Interventional Oncology Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Medtronic
15.1.1 Company Profile
15.1.2 Main Business and Interventional Oncology Information
15.1.3 SWOT Analysis of Medtronic
15.1.4 Medtronic Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.2 Boston Scientific
15.2.1 Company Profile
15.2.2 Main Business and Interventional Oncology Information
15.2.3 SWOT Analysis of Boston Scientific
15.2.4 Boston Scientific Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.3 BD
15.3.1 Company Profile
15.3.2 Main Business and Interventional Oncology Information
15.3.3 SWOT Analysis of BD
15.3.4 BD Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.4 Terumo
15.4.1 Company Profile
15.4.2 Main Business and Interventional Oncology Information
15.4.3 SWOT Analysis of Terumo
15.4.4 Terumo Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.5 Merit Medical
15.5.1 Company Profile
15.5.2 Main Business and Interventional Oncology Information
15.5.3 SWOT Analysis of Merit Medical
15.5.4 Merit Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.6 AngioDynamics
15.6.1 Company Profile
15.6.2 Main Business and Interventional Oncology Information
15.6.3 SWOT Analysis of AngioDynamics
15.6.4 AngioDynamics Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.7 J&J
15.7.1 Company Profile
15.7.2 Main Business and Interventional Oncology Information
15.7.3 SWOT Analysis of J&J
15.7.4 J&J Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.8 Teleflex
15.8.1 Company Profile
15.8.2 Main Business and Interventional Oncology Information
15.8.3 SWOT Analysis of Teleflex
15.8.4 Teleflex Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.9 Cook Medical
15.9.1 Company Profile
15.9.2 Main Business and Interventional Oncology Information
15.9.3 SWOT Analysis of Cook Medical
15.9.4 Cook Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.10 HealthTronics
15.10.1 Company Profile
15.10.2 Main Business and Interventional Oncology Information
15.10.3 SWOT Analysis of HealthTronics
15.10.4 HealthTronics Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.11 MedWaves
15.11.1 Company Profile
15.11.2 Main Business and Interventional Oncology Information
15.11.3 SWOT Analysis of MedWaves
15.11.4 MedWaves Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.12 Sanarus
15.12.1 Company Profile
15.12.2 Main Business and Interventional Oncology Information
15.12.3 SWOT Analysis of Sanarus
15.12.4 Sanarus Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.13 IMBiotechnologies
15.13.1 Company Profile
15.13.2 Main Business and Interventional Oncology Information
15.13.3 SWOT Analysis of IMBiotechnologies
15.13.4 IMBiotechnologies Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.14 Trod Medical
15.14.1 Company Profile
15.14.2 Main Business and Interventional Oncology Information
15.14.3 SWOT Analysis of Trod Medical
15.14.4 Trod Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.15 IceCure Medical
15.15.1 Company Profile
15.15.2 Main Business and Interventional Oncology Information
15.15.3 SWOT Analysis of IceCure Medical
15.15.4 IceCure Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.16 Mermaid Medicals
15.16.1 Company Profile
15.16.2 Main Business and Interventional Oncology Information
15.16.3 SWOT Analysis of Mermaid Medicals
15.16.4 Mermaid Medicals Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.17 Interface Biomaterials
15.17.1 Company Profile
15.17.2 Main Business and Interventional Oncology Information
15.17.3 SWOT Analysis of Interface Biomaterials
15.17.4 Interface Biomaterials Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
Please ask for sample pages for full companies list
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Interventional Oncology Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Interventional Oncology Market in North America (2020-2030)
8.1 Interventional Oncology Market Size
8.2 Interventional Oncology Market by End Use
8.3 Competition by Players/Suppliers
8.4 Interventional Oncology Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Interventional Oncology Market in South America (2020-2030)
9.1 Interventional Oncology Market Size
9.2 Interventional Oncology Market by End Use
9.3 Competition by Players/Suppliers
9.4 Interventional Oncology Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Interventional Oncology Market in Asia & Pacific (2020-2030)
10.1 Interventional Oncology Market Size
10.2 Interventional Oncology Market by End Use
10.3 Competition by Players/Suppliers
10.4 Interventional Oncology Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Interventional Oncology Market in Europe (2020-2030)
11.1 Interventional Oncology Market Size
11.2 Interventional Oncology Market by End Use
11.3 Competition by Players/Suppliers
11.4 Interventional Oncology Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Interventional Oncology Market in MEA (2020-2030)
12.1 Interventional Oncology Market Size
12.2 Interventional Oncology Market by End Use
12.3 Competition by Players/Suppliers
12.4 Interventional Oncology Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Interventional Oncology Market (2020-2025)
13.1 Interventional Oncology Market Size
13.2 Interventional Oncology Market by End Use
13.3 Competition by Players/Suppliers
13.4 Interventional Oncology Market Size by Type
Chapter 14 Global Interventional Oncology Market Forecast (2025-2030)
14.1 Interventional Oncology Market Size Forecast
14.2 Interventional Oncology Application Forecast
14.3 Competition by Players/Suppliers
14.4 Interventional Oncology Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Medtronic
15.1.1 Company Profile
15.1.2 Main Business and Interventional Oncology Information
15.1.3 SWOT Analysis of Medtronic
15.1.4 Medtronic Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.2 Boston Scientific
15.2.1 Company Profile
15.2.2 Main Business and Interventional Oncology Information
15.2.3 SWOT Analysis of Boston Scientific
15.2.4 Boston Scientific Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.3 BD
15.3.1 Company Profile
15.3.2 Main Business and Interventional Oncology Information
15.3.3 SWOT Analysis of BD
15.3.4 BD Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.4 Terumo
15.4.1 Company Profile
15.4.2 Main Business and Interventional Oncology Information
15.4.3 SWOT Analysis of Terumo
15.4.4 Terumo Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.5 Merit Medical
15.5.1 Company Profile
15.5.2 Main Business and Interventional Oncology Information
15.5.3 SWOT Analysis of Merit Medical
15.5.4 Merit Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.6 AngioDynamics
15.6.1 Company Profile
15.6.2 Main Business and Interventional Oncology Information
15.6.3 SWOT Analysis of AngioDynamics
15.6.4 AngioDynamics Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.7 J&J
15.7.1 Company Profile
15.7.2 Main Business and Interventional Oncology Information
15.7.3 SWOT Analysis of J&J
15.7.4 J&J Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.8 Teleflex
15.8.1 Company Profile
15.8.2 Main Business and Interventional Oncology Information
15.8.3 SWOT Analysis of Teleflex
15.8.4 Teleflex Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.9 Cook Medical
15.9.1 Company Profile
15.9.2 Main Business and Interventional Oncology Information
15.9.3 SWOT Analysis of Cook Medical
15.9.4 Cook Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.10 HealthTronics
15.10.1 Company Profile
15.10.2 Main Business and Interventional Oncology Information
15.10.3 SWOT Analysis of HealthTronics
15.10.4 HealthTronics Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.11 MedWaves
15.11.1 Company Profile
15.11.2 Main Business and Interventional Oncology Information
15.11.3 SWOT Analysis of MedWaves
15.11.4 MedWaves Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.12 Sanarus
15.12.1 Company Profile
15.12.2 Main Business and Interventional Oncology Information
15.12.3 SWOT Analysis of Sanarus
15.12.4 Sanarus Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.13 IMBiotechnologies
15.13.1 Company Profile
15.13.2 Main Business and Interventional Oncology Information
15.13.3 SWOT Analysis of IMBiotechnologies
15.13.4 IMBiotechnologies Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.14 Trod Medical
15.14.1 Company Profile
15.14.2 Main Business and Interventional Oncology Information
15.14.3 SWOT Analysis of Trod Medical
15.14.4 Trod Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.15 IceCure Medical
15.15.1 Company Profile
15.15.2 Main Business and Interventional Oncology Information
15.15.3 SWOT Analysis of IceCure Medical
15.15.4 IceCure Medical Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.16 Mermaid Medicals
15.16.1 Company Profile
15.16.2 Main Business and Interventional Oncology Information
15.16.3 SWOT Analysis of Mermaid Medicals
15.16.4 Mermaid Medicals Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
15.17 Interface Biomaterials
15.17.1 Company Profile
15.17.2 Main Business and Interventional Oncology Information
15.17.3 SWOT Analysis of Interface Biomaterials
15.17.4 Interface Biomaterials Interventional Oncology Sales, Revenue, Price and Gross Margin (2020-2025)
Please ask for sample pages for full companies list
Table Abbreviation And Acronyms
Table Research Scope Of Interventional Oncology Report
Table Data Sources Of Interventional Oncology Report
Table Major Assumptions Of Interventional Oncology Report
Table Interventional Oncology Classification
Table Interventional Oncology Applications
Table Drivers Of Interventional Oncology Market
Table Restraints Of Interventional Oncology Market
Table Opportunities Of Interventional Oncology Market
Table Threats Of Interventional Oncology Market
Table Raw Materials Suppliers
Table Different Production Methods Of Interventional Oncology
Table Cost Structure Analysis Of Interventional Oncology
Table Key End Users
Table Latest News Of Interventional Oncology Market
Table Merger And Acquisition
Table Planned/Future Project Of Interventional Oncology Market
Table Policy Of Interventional Oncology Market
Table 2020-2030 North America Interventional Oncology Market Size
Table 2020-2030 North America Interventional Oncology Market Size By Application
Table 2020-2025 North America Interventional Oncology Key Players Revenue
Table 2020-2025 North America Interventional Oncology Key Players Market Share
Table 2020-2030 North America Interventional Oncology Market Size By Type
Table 2020-2030 United States Interventional Oncology Market Size
Table 2020-2030 Canada Interventional Oncology Market Size
Table 2020-2030 Mexico Interventional Oncology Market Size
Table 2020-2030 South America Interventional Oncology Market Size
Table 2020-2030 South America Interventional Oncology Market Size By Application
Table 2020-2025 South America Interventional Oncology Key Players Revenue
Table 2020-2025 South America Interventional Oncology Key Players Market Share
Table 2020-2030 South America Interventional Oncology Market Size By Type
Table 2020-2030 Brazil Interventional Oncology Market Size
Table 2020-2030 Argentina Interventional Oncology Market Size
Table 2020-2030 Chile Interventional Oncology Market Size
Table 2020-2030 Peru Interventional Oncology Market Size
Table 2020-2030 Asia & Pacific Interventional Oncology Market Size
Table 2020-2030 Asia & Pacific Interventional Oncology Market Size By Application
Table 2020-2025 Asia & Pacific Interventional Oncology Key Players Revenue
Table 2020-2025 Asia & Pacific Interventional Oncology Key Players Market Share
Table 2020-2030 Asia & Pacific Interventional Oncology Market Size By Type
Table 2020-2030 China Interventional Oncology Market Size
Table 2020-2030 India Interventional Oncology Market Size
Table 2020-2030 Japan Interventional Oncology Market Size
Table 2020-2030 South Korea Interventional Oncology Market Size
Table 2020-2030 Southeast Asia Interventional Oncology Market Size
Table 2020-2030 Australia Interventional Oncology Market Size
Table 2020-2030 Europe Interventional Oncology Market Size
Table 2020-2030 Europe Interventional Oncology Market Size By Application
Table 2020-2025 Europe Interventional Oncology Key Players Revenue
Table 2020-2025 Europe Interventional Oncology Key Players Market Share
Table 2020-2030 Europe Interventional Oncology Market Size By Type
Table 2020-2030 Germany Interventional Oncology Market Size
Table 2020-2030 France Interventional Oncology Market Size
Table 2020-2030 United Kingdom Interventional Oncology Market Size
Table 2020-2030 Italy Interventional Oncology Market Size
Table 2020-2030 Spain Interventional Oncology Market Size
Table 2020-2030 Belgium Interventional Oncology Market Size
Table 2020-2030 Netherlands Interventional Oncology Market Size
Table 2020-2030 Austria Interventional Oncology Market Size
Table 2020-2030 Poland Interventional Oncology Market Size
Table 2020-2030 Russia Interventional Oncology Market Size
Table 2020-2030 Mea Interventional Oncology Market Size
Table 2020-2030 Mea Interventional Oncology Market Size By Application
Table 2020-2025 Mea Interventional Oncology Key Players Revenue
Table 2020-2025 Mea Interventional Oncology Key Players Market Share
Table 2020-2030 Mea Interventional Oncology Market Size By Type
Table 2020-2030 Egypt Interventional Oncology Market Size
Table 2020-2030 Israel Interventional Oncology Market Size
Table 2020-2030 South Africa Interventional Oncology Market Size
Table 2020-2030 Gulf Cooperation Council Countries Interventional Oncology Market Size
Table 2020-2030 Turkey Interventional Oncology Market Size
Table 2020-2025 Global Interventional Oncology Market Size By Region
Table 2020-2025 Global Interventional Oncology Market Size Share By Region
Table 2020-2025 Global Interventional Oncology Market Size By Application
Table 2020-2025 Global Interventional Oncology Market Share By Application
Table 2020-2025 Global Interventional Oncology Key Vendors Revenue
Table 2020-2025 Global Interventional Oncology Key Vendors Market Share
Table 2020-2025 Global Interventional Oncology Market Size By Type
Table 2020-2025 Global Interventional Oncology Market Share By Type
Table 2025-2030 Global Interventional Oncology Market Size By Region
Table 2025-2030 Global Interventional Oncology Market Size Share By Region
Table 2025-2030 Global Interventional Oncology Market Size By Application
Table 2025-2030 Global Interventional Oncology Market Share By Application
Table 2025-2030 Global Interventional Oncology Key Vendors Revenue
Table 2025-2030 Global Interventional Oncology Key Vendors Market Share
Table 2025-2030 Global Interventional Oncology Market Size By Type
Table 2025-2030 Interventional Oncology Global Market Share By Type
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Interventional Oncology Picture
Figure 2020-2030 North America Interventional Oncology Market Size And Cagr
Figure 2020-2030 South America Interventional Oncology Market Size And Cagr
Figure 2020-2030 Asia & Pacific Interventional Oncology Market Size And Cagr
Figure 2020-2030 Europe Interventional Oncology Market Size And Cagr
Figure 2020-2030 Mea Interventional Oncology Market Size And Cagr
Figure 2020-2025 Global Interventional Oncology Market Size And Growth Rate
Figure 2025-2030 Global Interventional Oncology Market Size And Growth Rate
Table Research Scope Of Interventional Oncology Report
Table Data Sources Of Interventional Oncology Report
Table Major Assumptions Of Interventional Oncology Report
Table Interventional Oncology Classification
Table Interventional Oncology Applications
Table Drivers Of Interventional Oncology Market
Table Restraints Of Interventional Oncology Market
Table Opportunities Of Interventional Oncology Market
Table Threats Of Interventional Oncology Market
Table Raw Materials Suppliers
Table Different Production Methods Of Interventional Oncology
Table Cost Structure Analysis Of Interventional Oncology
Table Key End Users
Table Latest News Of Interventional Oncology Market
Table Merger And Acquisition
Table Planned/Future Project Of Interventional Oncology Market
Table Policy Of Interventional Oncology Market
Table 2020-2030 North America Interventional Oncology Market Size
Table 2020-2030 North America Interventional Oncology Market Size By Application
Table 2020-2025 North America Interventional Oncology Key Players Revenue
Table 2020-2025 North America Interventional Oncology Key Players Market Share
Table 2020-2030 North America Interventional Oncology Market Size By Type
Table 2020-2030 United States Interventional Oncology Market Size
Table 2020-2030 Canada Interventional Oncology Market Size
Table 2020-2030 Mexico Interventional Oncology Market Size
Table 2020-2030 South America Interventional Oncology Market Size
Table 2020-2030 South America Interventional Oncology Market Size By Application
Table 2020-2025 South America Interventional Oncology Key Players Revenue
Table 2020-2025 South America Interventional Oncology Key Players Market Share
Table 2020-2030 South America Interventional Oncology Market Size By Type
Table 2020-2030 Brazil Interventional Oncology Market Size
Table 2020-2030 Argentina Interventional Oncology Market Size
Table 2020-2030 Chile Interventional Oncology Market Size
Table 2020-2030 Peru Interventional Oncology Market Size
Table 2020-2030 Asia & Pacific Interventional Oncology Market Size
Table 2020-2030 Asia & Pacific Interventional Oncology Market Size By Application
Table 2020-2025 Asia & Pacific Interventional Oncology Key Players Revenue
Table 2020-2025 Asia & Pacific Interventional Oncology Key Players Market Share
Table 2020-2030 Asia & Pacific Interventional Oncology Market Size By Type
Table 2020-2030 China Interventional Oncology Market Size
Table 2020-2030 India Interventional Oncology Market Size
Table 2020-2030 Japan Interventional Oncology Market Size
Table 2020-2030 South Korea Interventional Oncology Market Size
Table 2020-2030 Southeast Asia Interventional Oncology Market Size
Table 2020-2030 Australia Interventional Oncology Market Size
Table 2020-2030 Europe Interventional Oncology Market Size
Table 2020-2030 Europe Interventional Oncology Market Size By Application
Table 2020-2025 Europe Interventional Oncology Key Players Revenue
Table 2020-2025 Europe Interventional Oncology Key Players Market Share
Table 2020-2030 Europe Interventional Oncology Market Size By Type
Table 2020-2030 Germany Interventional Oncology Market Size
Table 2020-2030 France Interventional Oncology Market Size
Table 2020-2030 United Kingdom Interventional Oncology Market Size
Table 2020-2030 Italy Interventional Oncology Market Size
Table 2020-2030 Spain Interventional Oncology Market Size
Table 2020-2030 Belgium Interventional Oncology Market Size
Table 2020-2030 Netherlands Interventional Oncology Market Size
Table 2020-2030 Austria Interventional Oncology Market Size
Table 2020-2030 Poland Interventional Oncology Market Size
Table 2020-2030 Russia Interventional Oncology Market Size
Table 2020-2030 Mea Interventional Oncology Market Size
Table 2020-2030 Mea Interventional Oncology Market Size By Application
Table 2020-2025 Mea Interventional Oncology Key Players Revenue
Table 2020-2025 Mea Interventional Oncology Key Players Market Share
Table 2020-2030 Mea Interventional Oncology Market Size By Type
Table 2020-2030 Egypt Interventional Oncology Market Size
Table 2020-2030 Israel Interventional Oncology Market Size
Table 2020-2030 South Africa Interventional Oncology Market Size
Table 2020-2030 Gulf Cooperation Council Countries Interventional Oncology Market Size
Table 2020-2030 Turkey Interventional Oncology Market Size
Table 2020-2025 Global Interventional Oncology Market Size By Region
Table 2020-2025 Global Interventional Oncology Market Size Share By Region
Table 2020-2025 Global Interventional Oncology Market Size By Application
Table 2020-2025 Global Interventional Oncology Market Share By Application
Table 2020-2025 Global Interventional Oncology Key Vendors Revenue
Table 2020-2025 Global Interventional Oncology Key Vendors Market Share
Table 2020-2025 Global Interventional Oncology Market Size By Type
Table 2020-2025 Global Interventional Oncology Market Share By Type
Table 2025-2030 Global Interventional Oncology Market Size By Region
Table 2025-2030 Global Interventional Oncology Market Size Share By Region
Table 2025-2030 Global Interventional Oncology Market Size By Application
Table 2025-2030 Global Interventional Oncology Market Share By Application
Table 2025-2030 Global Interventional Oncology Key Vendors Revenue
Table 2025-2030 Global Interventional Oncology Key Vendors Market Share
Table 2025-2030 Global Interventional Oncology Market Size By Type
Table 2025-2030 Interventional Oncology Global Market Share By Type
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Interventional Oncology Picture
Figure 2020-2030 North America Interventional Oncology Market Size And Cagr
Figure 2020-2030 South America Interventional Oncology Market Size And Cagr
Figure 2020-2030 Asia & Pacific Interventional Oncology Market Size And Cagr
Figure 2020-2030 Europe Interventional Oncology Market Size And Cagr
Figure 2020-2030 Mea Interventional Oncology Market Size And Cagr
Figure 2020-2025 Global Interventional Oncology Market Size And Growth Rate
Figure 2025-2030 Global Interventional Oncology Market Size And Growth Rate
Research Methodology
- Market Estimated Methodology:
Bottom-up & top-down approach, supply & demand approach are the most important method which is used by HDIN Research to estimate the market size.
1）Top-down & Bottom-up Approach
Top-down approach uses a general market size figure and determines the percentage that the objective market represents.
Bottom-up approach size the objective market by collecting the sub-segment information.
2）Supply & Demand Approach
Supply approach is based on assessments of the size of each competitor supplying the objective market.
Demand approach combine end-user data within a market to estimate the objective market size. It is sometimes referred to as bottom-up approach.
- Forecasting Methodology
- Numerous factors impacting the market trend are considered for forecast model:
- New technology and application in the future;
- New project planned/under contraction;
- Global and regional underlying economic growth;
- Threatens of substitute products;
- Industry expert opinion;
- Policy and Society implication.
- Analysis Tools
1）PEST Analysis
PEST Analysis is a simple and widely used tool that helps our client analyze the Political, Economic, Socio-Cultural, and Technological changes in their business environment.
- Benefits of a PEST analysis:
- It helps you to spot business opportunities, and it gives you advanced warning of significant threats.
- It reveals the direction of change within your business environment. This helps you shape what you’re doing, so that you work with change, rather than against it.
- It helps you avoid starting projects that are likely to fail, for reasons beyond your control.
- It can help you break free of unconscious assumptions when you enter a new country, region, or market; because it helps you develop an objective view of this new environment.
2）Porter’s Five Force Model Analysis
The Porter’s Five Force Model is a tool that can be used to analyze the opportunities and overall competitive advantage. The five forces that can assist in determining the competitive intensity and potential attractiveness within a specific area.
- Threat of New Entrants: Profitable industries that yield high returns will attract new firms.
- Threat of Substitutes: A substitute product uses a different technology to try to solve the same economic need.
- Bargaining Power of Customers: the ability of customers to put the firm under pressure, which also affects the customer's sensitivity to price changes.
- Bargaining Power of Suppliers: Suppliers of raw materials, components, labor, and services (such as expertise) to the firm can be a source of power over the firm when there are few substitutes.
- Competitive Rivalry: For most industries the intensity of competitive rivalry is the major determinant of the competitiveness of the industry.
3）Value Chain Analysis
Value chain analysis is a tool to identify activities, within and around the firm and relating these activities to an assessment of competitive strength. Value chain can be analyzed by primary activities and supportive activities. Primary activities include: inbound logistics, operations, outbound logistics, marketing & sales, service. Support activities include: technology development, human resource management, management, finance, legal, planning.
4）SWOT Analysis
SWOT analysis is a tool used to evaluate a company's competitive position by identifying its strengths, weaknesses, opportunities and threats. The strengths and weakness is the inner factor; the opportunities and threats are the external factor. By analyzing the inner and external factors, the analysis can provide the detail information of the position of a player and the characteristics of the industry.
- Strengths describe what the player excels at and separates it from the competition
- Weaknesses stop the player from performing at its optimum level.
- Opportunities refer to favorable external factors that the player can use to give it a competitive advantage.
- Threats refer to factors that have the potential to harm the player.
- Data Sources
| Primary Sources | Secondary Sources |
|---|---|
| Face to face/Phone Interviews with market participants, such as: Manufactures; Distributors; End-users; Experts. Online Survey |
Government/International Organization Data: Annual Report/Presentation/Fact Book Internet Source Information Industry Association Data Free/Purchased Database Market Research Report Book/Journal/News |